
TRACON Pharmaceuticals Investor Relations Material
Latest events

Q1 2024
TRACON Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TRACON Pharmaceuticals Inc
Access all reports
TRACON Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing targeted therapies for cancer. The company’s approach includes working with partners to advance drug candidates that address unmet medical needs in oncology. TRACON's pipeline consists of small molecules and biologics designed to treat various cancer types by inhibiting tumor growth and progression. The company also offers its expertise in clinical development and regulatory management to support its collaborations. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TCON
Country
🇺🇸 United States